Article thumbnail

Monitoring and treatment of anti-D in pregnancy

By D. Bettelheim, S. Panzer, H. W. Reesink, B. Csapo, C. Pessoa, F. Guerra, S. Wendel, P. Calda, U. Sprogøe, M. Dziegiel, A. Aitokallio-Tallberg, S. Koskinen, M. Kuosmanen, T. J. Legler, W. Stein, S. Villa, M. A. Villa, L. Trespidi, B. Acaia, F. P. H. A. Vandenbussche, A. Brand, M. de Haas, H. H. H. Kanhai, D. Gounder, P. Flanagan, R. Donegan, E. Parry, C. Sefonte, S. M. Skulstad, T. Hervig, Ø Flesland, B. Zupa ska, M. Uhrynowska, O. Lapaire, X. Y. Zhong and W. Holzgreve


Prophylactic anti-D is a very safe and effective therapy for the suppression of anti-D immunization and thus prevention of haemolytic disease of the foetus and newborn. However, migration from countries with low health standards and substantial cuts in public health expenses have increased the incidence of anti-D immunization in many "developed" countries. Therefore, this forum focuses on prenatal monitoring standards and treatment strategies in pregnancies with anti-D alloimmunization. The following questions were addressed, and a response was obtained from 12 centres, mainly from Europe

Publisher: 'Wiley'
Year: 2010
DOI identifier: 10.1111/j.1423-0410.2010.01322.x
OAI identifier:
Provided by: edoc
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles